Thebes Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.16 M
- Company Age 21 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -12.60%
- Profit Growth 981.83%
- Ebitda 313.02%
- Net Worth 34.18%
- Total Assets 55.97%
About Thebes Pharmaceuticals
Thebes Pharmaceuticals Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 April 2003 and has a history of 21 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.16 M, as per Ministry of Corporate Affairs (MCA) records.
Anindita Mukherjee, Hemant Kumar, and Rakesh Taneja serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231DL2003PTC119735
-
Company No.
119735
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Apr 2003
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Thebes Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemant Kumar
|
Director | 21-Aug-2023 | Current |
|
Anindita Mukherjee
|
Whole-Time Director | 25-Mar-2004 | Current |
|
Rakesh Taneja
|
Director | 03-Apr-2003 | Current |
Financial Performance of Thebes Pharmaceuticals.
Thebes Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 12.6% decrease. The company also saw a substantial improvement in profitability, with a 981.83% increase in profit. The company's net worth Soared by an impressive increase of 34.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thebes Pharmaceuticals?
In 2020, Thebes Pharmaceuticals had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Gaupur Agro And Poultry Private LimitedAnindita Mukherjee is a mutual person
-
Ace Digital Accounting Solutions Private Limited
Anindita Mukherjee is a mutual person
-
Megha Peripherals Private Limited
Hemant Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Thebes Pharmaceuticals?
Unlock and access historical data on people associated with Thebes Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thebes Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thebes Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
